Abstract:Ethnopharmacological relevance: Boiled silkworm cocoons have been used to treat 'Xiaoke disease' (diabetes mellitus) recorded in Chinese medicine for over 800 years. In recent years, it has been found that the active substance silk sericin (SS) has therapeutic benefits in treating type 2 diabetes mellitus (T2DM). SS promotes pancreatic islet signalling, the proliferation of pancreatic islet cells, and insulin secretion. It is inferred that SS enters the bloodstream after oral administration and plays a role in the body's circulation. As a natural protein, SS needs to resist digestion by proteases in the gastrointestinal tract and cross the gastrointestinal barrier after oral administration. It is currently unclear how SS crosses the gastrointestinal barrier and whether it exerts therapeutic effects on T2DM by entering the circulation. Aim of the study: To study how SS crosses the gastrointestinal barrier and whether it enters the body circulation to exert a therapeutic effect on T2DM. Materials and methods: SS was extracted from silkworm cocoons using an alkaline method with sodium carbonate. The antidigestive capacity of SS was detected using SDS-PAGE gel electrophoresis experiments. The mode of uptake and translocation of orally consumed SS in vivo was analysed using the AP-side to BL-side and BL-side-AP-side translocations, apparent Permeability coefficient (Papp), and Exocytosis rates (ER). The study compared the differences between the adSS group and the adSS + EDTA group by using Ethylenediaminetetraacetic acid (EDTA) to separate the tight junctions between Caco-2 cells. The aim was to analyze whether the transport mode of oral filaggrin proteins in vivo could be absorbed by bypass transport. By administering SS through oral and intraperitoneal injection to type 2 diabetic mice, we measured its concentration in the blood, as well as blood glucose and insulin levels, to determine its effectiveness in treating diabetes and its ability to enter the body's circulation for treatment. Results: The molecular weight of SS decreased from 10k∼25 kDa to 10k∼15 kDa after in vitro simulated gastrointestinal fluid digestion, indicating its good antidigestive properties. The apparent Papp was greater than 1 × 10-6 cm·s-1, and the ER was between 0.5 and 1.5, indicating that adSS was well-absorbed and mainly passively transported. The Caco-2 cell model showed that the addition of EDTA promoted the transport of adSS, resulting in significantly larger Papp and ER values, indicating that adSS was absorbed by bypass transport. After oral administration of SS, the concentration of SS in the blood was lower than after intraperitoneal injection, which is 60% of intraperitoneal administration. Mice with a T2DM model who were administered SS for 5 weeks showed significant improvement in insulin resistance and glucose tolerance. Additionally, the pancreatic tissue appeared more regular. In the treatment of T2DM, injections of SS have been shown to be more effective than oral administration. Both oral and intraperitoneal injections have been partially involved in the circulation. Conclusions: SS is enzymatically cleaved by proteolytic enzymes in the gastrointestinal tract. The smaller molecules are partially absorbed into the body's circulation through passive and paracrine transport, exerting a therapeutic effect on T2DM.

Reducing Blood Glucose Levels in TIDM Mice with an Orally Administered Extract of Sericin from Higf-I-transgenic Silkworm Cocoons.

Reducing blood glucose level in TIDM mice by orally administering the silk glands of transgenic hIGF-I silkworms

Lowering the blood glucose of diabetes mellitus mice by oral administration with transgenic human insulin-like growth factor I silkworms.

A Transgenic Bm Cell Line of Piggybac Transposon-Derived Targeting Expression of Humanized Glycoproteins Through N-glycosylation.

A Shark Liver Gene-Derived Active Peptide Expressed in the Silkworm, Bombyx Mori: Preliminary Studies for Oral Administration of the Recombinant Protein.

Silk Sericin Has Significantly Hypoglycaemic Effect in Type 2 Diabetic Mice Via Anti-Oxidation and Anti-Inflammation

Expression of Higf-I in the Silk Glands of Transgenic Silkworms and in Transformed Silkworm Cells

Oral administration of CTB insulin B chain produced in silkworm delays the diabetes development in NOD mice

Expression of Human Insulin-like Growth Factor Ⅰ in Transgenic Silkworm Mediated by Non-transposon Vector

Expression of the Higf-I Gene Driven by the Fhx/P25 Promoter in the Silk Glands of Germline Silkworm and Transformed BmN Cells.

Spider Silk Fibroin Protein Heterologously Produced in Rice Seeds Reduce Diabetes and Hypercholesterolemia in Mice.

A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery.

Mechanism of Silk Secretion Revealed by Proteomic Analysis of Silkworm Cocoons with Fibroin Light Chain Mutations.

Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein

Therapeutic effects of ethanolic extract from the green cocoon shell of silkworm Bombyx mori on type 2 diabetic mice and its hypoglycaemic mechanism

Therapeutic Effects of Ethanolic Extract from the Green Cocoon Shell of Silkwormbombyx Morion Type 2 Diabetic Mice and Its Hypoglycaemic Mechanism

High-Efficiency Production Of Human Serum Albumin In The Posterior Silk Glands Of Transgenic Silkworms, Bombyx Mori L

Advanced Silk Material Spun by a Transgenic Silkworm Promotes Cell Proliferation for Biomedical Application.

Oral sericin ameliorates type 2 diabetes through passive intestinal and bypass transport into the systemic circulation

Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes

Human epidermal growth factor-functionalized cocoon silk with improved cell proliferation activity for the fabrication of wound dressings